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Purpose: The aim of this study was to evaluate this clinical outcome of neonatal pelvis dilatation 
in very low birth weight (VLBW) infants.
Methods: The medical records of 127 VLBW infants admitted to two neonatal intensive care units 
from January 2012 to December 2014 were retrospectively analyzed. Renal pelvis dilatation was 
diagnosed via ultrasound examination with cases divided into 3 groups: mild (dilatation of 5-10 
mm), moderate (11-15 mm) and severe (≥15 mm). The correlation between the 3 dilatation groups 
and progression into hydronephrosis was evaluated. 
Results: Among the 127 premature infants, renal pelvis dilatation was identified in 29 (22.8%) 
on ultrasound examination performed, on average 13.3 days after birth, combined with calyceal 
ectasia in 5 (3.9%) infants. At a postmenstrual age of 40 weeks, 18 infants (14.2%) had renal pelvis 
dilatation, 6 (5%) infants accompanied by a dilatation of the calyx. On the last follow-up performed 
when children were not older than 2 years old, renal pelvis dilatation had resolved to within normal 
limits in 23 (79%) infants while persisting in 6 (21%) infants; 1 mild, 3 moderate, and 2 severe pelvis 
dilatation. The median time-to-recovery of dilatation was 10.5 months (Kaplan-Meier curve), re-
gardless of the severity of dilatation at birth. Based on receiver operating curve analysis, a cutoff 
diameter of renal dilatation at birth of 11.35 mm predicted persisting severe dilatation at the final 
follow-up (sensitivity 83.3%, specificity 82.6%).
Conclusion: Although premature infants with dilatation of mild severity were all recovered, some 
of those with moderate-to-severe dilatation progressed to hydronephrosis. Therefore careful 
follow-up of premature infants with renal pelvis dilatation is recommended.
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Introduction
Renal pelvis dilatation occurs in 1-2% of fetuses.
1,2
 As renal pelvis antero-posterior (AP) 
diameters vary with gestational age, antenatal diagnosis of hydronephrosis is based on 
different criteria for each trimester of pregnancy.
3-5
 Although the Society for Fetal Urology 
has published a consensus statement regarding the criteria for antenatal diagnosis of 
hydronephrosis,
6
 these criteria have not been globally adopted. Therefore a unified de-
finition and grading of renal pelvis dilatation does not currently exist. As an example 
postnatal renal pelvis dilatation has been defined using multiple measurement categories, 
such as a dilatation ≥5 mm or ≥7 mm,
7,8
 with other grading systems defining moderate 
dilatation as an AP diameter >10 mm and severe dilatation as an AP diameter ≥15 mm.
9-11
Studies have reported an association between renal pelvis dilatation and postnatal 
pro gression to other renal diseases, including renal anomalies in 62% of cases of renal 
pelvis dilatation and significant uropathy in 39% of cases.
10
 An analysis of the progres-
sion to renal disease based on gestational age indicated that 12% of infants showing 
pelvis dilatation in the second trimester developed uropathy such as renal duplication, 
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vesico-ureteral reflux (VUR) and ureteropelvic junction ob-
struction (UPJO), while 69% of those showing pelvis dilata-
tion in the third trimester developed renal anomalies. An 
AP diameter ≥7 mm in the third trimester is a predictive 
indicator of postnatal uropathy.
12
Treatment for renal pelvis dilatation is based on the severity 
of the condition. Ninety percent of infants with a mild dila-
tation did not require surgical treatment, while 17% of infants 
with moderate dilatation and all infants with severe dilatation 
progressed to obstruction of the pyelo-ureteral junction, 
which required surgical treatment.
12,13
 Based on this evidence, 
close follow-up monitoring of infants with severe hydrone-
phrosis for up 2 years was recommended.
13,14
 Others reported 
that 87% of infants with hydronephrosis recovered with 
only conservative management.
15,16
 Among Korean infants 
diag nosed with hydronephrosis on antenatal ultrasound 
exami nation, 47% of infants were confirmed ureteropelvic 
obstruc tion or vesicoureteral reflux, and only 10% of them 
were required surgical treatment.
17
 Therefore renal pelvis 
dilata tion is an important predictive factor of subsequent 
uropathy re quiring surgical treatment that depends on the 
severity of dilatation.
18
 However reported outcomes of renal 
pelvis dilatation at birth have varied widely among different 
institutions and different studies. Studies to date have either 
not included premature infants or have not specifically eva-
luated outcomes relative to prematurity. Therefore the aim of 
our study was to specifically evaluate the clinical progression 
of renal pelvis dilatation identified at birth, in very low birth 
weight (VLBW) infants. 
 
Materials and methods 
One hundred forty VLBW infants had been treated in 
the intensive care unit at Severance Hospital and Gangnam 
Severance Hospital, between January 2012 and December 
2014 and 13 expired infants were excluded. All VLBW infants 
who admitted were performed general blood tests, renal 
function tests, urine tests and ultrasound. The medical re-
cords of 127 VLBW infants who had undergone renal ultra-
sound examination in the neonatal intensive care unit, were 
reviewed for this study. Dilatation was defined by AP dia-
meter ≥5 mm on renal ultrasound examination.
3
 A diameter 
between 10 mm and 15 mm was defined as a moderate 
dilatation, with severe dilatation defined as a diameter >15 
mm, based on a previously published grading system of fetal 
pelvis dilatation in the third trimester (Fig. 1).
8,19
 Outcomes 
were eva luated by ultrasound examination performed at a 
postmen strual age (PMA) of 40 weeks, with the final follow-
up exa mination performed when children were not older 
than 2 years old. All ultrasound examinations and renal 
measure ments were performed by staff radiologists in both 
hospitals. Ethical approval was obtained from the ethics 
committees of Severance Children’s Hospital and Gangnam 
Severance Hospital.
All statistical analyses were performed using the SPSS 
software v.23 (IBM Corp., Armonk, NY., USA). A P-value 
<0.05 was considered statistically significant. Kaplan-Meier 
curves were used to estimate the recovery from pelvis dila-
tation using lifetime data. A log-rank test was performed to 
compare the probability of recovery among the three seve-
rity-based groups: mild, moderate and severe. We calculated 
receiver operating characteristic (ROC) curves to predict the 
risk of persisting renal pelvis dilatation at last follow-up. We 
also performed a sensitivity analysis to determine the optimal 
cutoff points for predicting persistent dilatation using ROC 
curves. 
 
Results
Our study group of 127 VLBW infants included 60 males 
and 67 females, with a mean±standard deviation gestational 
age of 29.2±2.8 weeks (range 24.1 to 36.1), and a birth weight 
of 1,120.4±237.2 g (range 400 to 1,490) (Table 1). All infants 
performed prenatal ultrasound and there was only one 
infant who has renal pelvis dilatation. The initial ultrasound 
examination was performed, on average, 13.3 days (range 1 
to 78 days) after birth, with the last ultrasound examination 
performed, on average, 6.3 months (range 1 to 24 months) 
after birth. If the initial ultrasound examination showed ab-
normal findings, re peated ultrasound examinations were 
performed up until the point of recovery (i.e., normal find-
ings on examination) or up to 2 years of age. The distribu-
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per sisting in 6 infants, 3 with bilateral dilation and 3 with a 
dila tation only on the left side. Recovery from a renal pelvis 
dilation of moderate severity was identified in 5 patients 
(from 8 infants at birth to 3 infants at the last follow-up) and 
from a severe dilatation was found in 3 patients (from 5 in-
fants at birth to 2 infants at the last follow-up). Therefore, 
recovery from a severe dilatation of the renal pelvis may be 
possible but is likely to occur over a longer period. Renal 
cor tical echogenicity increased in 6 (5%) infants, with ne-
phrocalcinosis identified in 2 (2%) infants (Table 2). 
Clinical progress of the infants with renal pelvis dilatation 
is shown in Fig. 2. The number of infants diagnosed with 
renal pelvis dilation only decreased from 24 to 3, while the 
number of infants with pelvis dilatation accompanied by 
dilatation of the calyx decreased from 5 to 3. An overall inci-
dence rate of urinary tract infection of 12% was identified, 
including 5 infants with pelvis dilatation identified on initial 
ultrasound examination. Identified pathogens were as follows; 
Enterococcus (47%), Escherichia coli (18%), Enterobacter 
(12%), Coagulase negative staphylococci (6%), Klebsiella (6%), 
tion of findings on ultrasound examinations is summarized in 
Table 2. 
Initial ultrasound examination at birth was unremarkable in 
98 (77%) infants, with a renal pelvis dilatation identified in 29 
(22%) infants. In terms of the distribution of renal pelvis dila-
tation, 10 infants presented with bilateral dilatation, 18 with 
dilatation on the left side, and 1 with a dilatation on the right 
side. In 5 infants, renal pelvis dilatation was accompanied 
with a dilated calyx, which was clinically diagnosed as hy-
dronephrosis. Bilateral hydronephrosis was identified in 1 
infant and left-sided hydronephrosis in 4 infants. Kidney 
echogenicity was identified in 21 (17%) infants, nephrocalci-
nosis was identified in 2 (2%) infants (Table 2). 
At PMA 40 weeks, 109 infants (86%) had unremarkable 
ultrasonography examinations, with renal pelvis dilatation 
persisting in 18 infants (14%). Among these infants, pelvis 
dilatation was evident on both sides in 8 and isolated to the 
left side in 10. Among these 18 infants, renal pelvis dilatation 
was accompanied by a dilatation of the calyx in 6 infants, 
1 with bilateral dilatation of the calyx and 5 with left-sided 
dilatation. With regards to the severity, renal pelvis dilatation 
was considered to be mild in 10 infants, moderate in 5 and 
severe in 3. Kidney echogenicity increased in 8 (6%) infants 
and nephrocalcinosis was identified in 2 (2%) infants. For the 
remaining 12 infants with pelvis dilatation only, the extent 
of dilatation showed decreasing trends at the PMA 40 week 
(Table 2). 
Over our follow-up period, the renal pelvis dilatation re-
solved to within normal limits in 23 (79%) infants, while 
Table 1. Demographic Characteristics of Very Low Birth Weight Infants 
Demographic N=127
Male 60 (47%) 
Gestational age (weeks, mean±SD) 29.2±2.8 
Gestational age groups
  <30 wks 85 (67%)
  ≥30 wks 42 (33%)
Birth weight (g, mean±SD) 1,120.4±237.2
Prenatal diagnosis of pelvic dilatation 1 (1%)
Age at first evaluation of renal ultrasonography (day, mean±SD) 13.3±14.1
Age at the last follow up renal ultrasound (month, mean±SD) 6.3±7.8
Data as absolute numbers; percentages in parentheses. 
Table 2. Renal Ultrasonography Findings from Birth to Last Follow-up 
Findings At birth At PMA 40 weeks  
†At last
Follow-up
No pelvis dilatation 98 (78%) 109 (86%) 121 (95%)
Pelvis dilatation only 24 (19%) 12 (9%) 3 (2%)
  Both 9 (7%) 7 (6%) 2 (2%)
  Left 14 (11%) 5 (4%) 1 (1%)
  Right 1 (1%) 0 (0%) 0 (0%)
Pelvis dilatation+Calyx dilatation 5 (4%) 6(5%) 3(2%)
  Both 1 (1%) 1 (1%) 1 (1%)
  Left 4 (3%) 5 (4%) 2 (2%)
  Right 0 (0%) 0 (0%) 0 (0%)
‡Severity of pelvis dilatation 29 (23%) 18 (14%) 6(5%)
  Mild 16 (13%) 10 (8%) 1 (1%)
  Moderate 8 (6%) 5 (4%) 3 (2%)
  Severe 5 (4%) 3 (2%) 2 (2%)
Increased renal echogenicity 21 (17%) 8 (6%) 6 (5%)
Nephrocalcinosis 2 (2%) 2 (2%) 2 (2%)
*Data as absolute numbers; percentages in parentheses. 
‡Severity is defined by an AP diameter of renal pelvis. AP diameter of 5-10 mm is 
defined as mild severity, and diameters of 10-15 mm and >15 mm as moderate 
and severe dilatations, respectively.
†Last follow-up performed when children were not older than 2 years old.
Abbreviation: PMA, postmenstural age.
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renal pelvis dilatation at the last follow-up was 0.88 (P=0.005). 
The estimated optimal cutoff points to predict remaining pelvis 
dilatation at last follow up was an AP diameter of 11.35 mm 
(sensitivity 83.3%, specificity 82.6%).
Discussion 
Renal pelvis dilatation is an important predictive factor of 
subsequent nephronuropathy. Although several studies have 
reported on the clinical progression of infantile renal pelvis 
dilatation
20
, the clinical progression in VLBW premature in-
fants has not been previously evaluated. We found that most 
infants with pelvis dilatation showed recovery and that a 
dilatation ≥11.35 mm was a risk factor for persisting pelvis 
dilatation. 
Lyn et al. measured the AP diameter in 180 fetuses to de-
termine the 10
th
, 50
th
, and 90
th
 percentile values by gestational 
age. The AP diameter increased in direct proportion to gesta-
tional age, with a 90
th
 percentile value of 5.0 mm in the se-
cond trimester, compared to 50
th
 and 90
th
 percentile values of 
4.0 mm and 7.0 mm in the third trimester.
21
 The mean gesta-
tional age of VLBW infants enrolled in our study was 29.2 
weeks and, therefore, we graded the severity of renal pelvis 
dilatation based on measurements for the third trimester. 
Due to many study variation, researchers and clinicians have 
argued that a renal pelvis dilatation >5 mm, regardless of ge-
stational age, is a predictive factor for postnatal nephrouro-
pathies, with these infants requiring close follow-up and 
medical care.
3
 Therefore, in our study, we considered an AP 
diameter >5 mm to be an abnormal finding. Based on a pre-
viously published grading of antenatal renal pelvis dilatation 
and Candida (6%). Therefore, the specific incidence rate of 
urinary tract infection among infants with an identified renal 
pelvis dilation at birth was 17%, indicating that pelvis dila-
tation was not a specific risk factor for urinary tract infection. 
Among infants with pelvis dilatation and those with hydro-
nephrosis, 63% and 40% were males, respectively.
The recovery of renal pelvis dilatation based on lifetime 
data using Kaplan Meier curves was estimated to occur at a 
median age of 10.5 months (range 1-18 months; 25
th
 percentile: 
5.1 months; 75
th
 percentile: 15.1 months; Fig. 3). When the 
VLBW infants with pelvis dilatation at birth were divided into 
three groups (mild, moderate and severe), no significant bet-
ween-group differences using log rank test in the rate of re-
covery were identified (Fig. 3). 
ROC curves are shown in Fig. 4. The AUC for persisting 
A B C 
Fig. 1. Ultrasound findings of pelvis dilatation. (A) severe pelvis dilatation (B) moderate pelvis 
dilatation (C) mild pelvis dilatation.
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Fig. 2. Clinical progress of the infants with renal pelvis dilatation. 
Abbreviation: PMA, postmenstural age.
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in the third trimester,
8,19
 we defined a dilatation of 5-10 mm 
as being of mild severity, with diameters of 10-15 mm and 
>15 mm as moderate and severe dilatations, respectively. 
Fetal pelvis dilatation is the most common anomaly detected 
on prenatal mid-trimester ultrasound. Male fetuses exhibit a 
significantly higher frequency of renal pelvis dilatation than 
female fetuses, possibly owing a high rate of spontaneous 
resolution. Khalid reported an overall incidence rate of pelvis 
dilatation of 4.5% in fetuses.
10
 The higher prevalence of renal 
pelvis dilatation among premature infants, compared to all 
other infants born at term, might be suggested; however the 
frequency in preterm infants has not been reported yet. In 
this study, 19% of VLBW infants presented with pelvis dilata-
tion, and persisting pelvis dilatation through the last follow-
up was observed in 5% of cases. 
The fact that renal pelvis dilatation is a good prognostic 
factor for subsequent renal diseases has been confirmed in a 
number of previously published studies.
22,23
 Khalid reported 
that 69% of infants with pelvis dilatation in the third trimester 
on fetal ultrasound were diagnosed with a renal anomaly 
postnatally.
10,24
 Bouzada conducted a follow-up study of 103 
newborn infants with an AP diameter ≥5 mm, providing 
evidence of the sensitivity and specificity of diameters of 7.5 
mm and 15 mm as predictive factors of uropathy and the 
need for surgical interventions, respectively.
12
 In our retro-
spective study, among infants diagnosed with severe renal 
pelvis dilatation (>15 mm), none progressed to uropathy or 
required surgical intervention during our follow-up period. 
Therefore, we could not validate the usefulness of pelvis 
dila tation in VLBW infants as a predictive factor for postnatal 
Fig. 4. Diagnostic accuracy of AP diameter for the diagnosis of severe 
pelvic dilatation. Area under the curve (AUC) values were obtained 
from receiver operating characteristic (ROC) curve analysis.
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Fig. 3. Days to the recovery of renal pelvis dilatation in VLBW infants using Kaplan Meier curves. Quartile 
estimates according to the time variable duration showed as follows; 25 percentile of the recovery of renal 
pelvis dilatation occurred after the 5 months from birth, 50% percentile after 10.5 months from birth, and 75 
percentile after 15.1 month from birth. No significant differences in the rate of recovery using log rank test were 
identified among three groups (mild, moderate and severe).
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uropathy. However, an AP diameter ≥11.35 mm was predic-
tive of a persisting dilatation at the last follow-up, with a 
sensitivity of 83.3% and a specificity of 82.6%. 
Among the 29 infants in our study with a renal pelvis dila-
tation diagnosed at the initial renal ultrasound examination, 
23 (79.3%) infants recovered normal renal diameters over the 
follow-up period. However, 88% of infants diagnosed with 
renal pelvis dilation only showed the improvement, while 
40% of infants with pelvis dilatation accompanied by dila-
tation of the calyx showed the improvement. It means that 
renal pelvis dilatation accompanied by calyceal dilatation is 
more difficult to recover than renal pelvis dilatation only. 
Moreover, the remaining 6 infants did not require surgical 
intervention over the follow-up period. 
We recognize that previous studies evaluating the long-
term clinical outcomes of infantile renal pelvis dilatation have 
reported various outcomes regarding uropathy. In case series 
of 19 infants with severe hydronephrosis (G3, 4), Onen re-
ported the need for surgical intervention in 35% of cases.
14
 
In contrast, in a case series of 16 infants with moderate-to-
severe bilateral hydronephrosis, Bajpai reported that 78% 
recovered without treatment, with 12.5% requiring unilateral 
pyeloplasty.
16
 Another study reported that 87% of infants 
with hydronephrosis and obstruction of the ureteropelvic 
junction recovered with conservative management.
15,16
 Based 
on previous data, close follow-up of infants with severe 
hydronephrosis for up 2 years is recommended.
13,14
 In this 
study, the recovery of renal pelvis dilatation was estimated at 
a median age of 10.5 months (range 1-18 months), with the 
time to recovery being independent of the severity of the 
dilatation at initial assessment. 
In the interpretation of our results, it is important to note 
that our study group was small and that the follow-up was 
conducted over a limited time period. As further surgical 
intervention may occur after infancy, a long-term follow-up 
is necessary. 
In conclusion, although premature infants with dilatation 
of mild severity are expected to recover, those with a mode-
rate-to-severe dilatation are at risk of progressing to hydro-
nephrosis. But there was no significant difference among the 
groups of severity in the rate of recovery. And the estimated 
optimal cutoff points to predict remaining pelvis dilatation at 
last follow up was an AP diameter of 11.35 mm (sensitivity 
83.3%, specificity 82.6%). Based on current evidence, we re-
commend that kidney evaluation by ultrasonography should 
be continued until confirmation of recovery of the dilatation. 
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